Rocket Pharmaceuticals (RCKT) said Wednesday that it has priced an upsized public offering of 13.2 million shares at $12.50 each, expected to raise $165 million in gross proceeds.
The company said the offering, slated to close around Thursday, includes a 30-day option for underwriters to purchase an additional 1.98 million shares.
Shares of the company were down 6% in recent Wednesday premarket activity.
Price: 12.71, Change: -0.80, Percent Change: -5.92
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.